Ken Griffin Lixte Biotechnology Hldgs Inc Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Lixte Biotechnology Hldgs Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 32,122 shares of LIXTW stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,122

Holding current value

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 14, 2024	BUY	N/A	32,122 New	32,122 $0
Q1 2023 May 15, 2023	BUY	N/A	11,067 New	11,067 $0

Others Institutions Holding LIXTW

# of Institutions

Shares Held

139K

Call Options Held

Put Options Held

Ethos Financial Group, LLC King Of Prussia, PA

42.1K
Shares

$0
0.0% of portfolio
Warberg Asset Management LLC Winnetka, IL

37.9K
Shares

$0
0.0% of portfolio
Clear Street LLC

23.2K
Shares

$0
0.0% of portfolio
Ubs Group Ag

4.09K
Shares

$0
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About LIXTE BIOTECHNOLOGY HLDGS INC

Ticker LIXTW

More about LIXTW

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account